Blog
Can KLA's Greenfield Fab Exposure Spark Multi-Year Revenue Growth?
KLA Corporation KLAC appears well-positioned to capitalize on the semiconductor industry’s next wave of greenfield fab investments, driven largely by booming AI infrastructure demand and expanding
HOOD Stock Retreats After 2025 Rally: Should You Stay Invested?
After a record-breaking rally in 2025, shares of Robinhood Markets HOOD have pulled back sharply in 2026, falling 25% year to date. The decline appears to reflect profit-taking after last year’s
Can CRUS' Audio Converter Launch Diversify Revenue Streams & Boost Sales?
The professional and prosumer audio industry is evolving rapidly. Against this backdrop, Cirrus Logic CRUS has recently introduced a new portfolio of nine audio converters, including
Will Autonomous Agent Growth Accelerate CRWV's Data Center Utilization?
The rapid rise of autonomous AI agents is creating favorable demand for cloud infrastructure, and few companies are better positioned to benefit than CoreWeave, Inc. CRWV. As enterprises move beyond
Costco Q3 Earnings Beat on Strong Membership and Digital Growth
Costco Wholesale Corporation COST reported third-quarter fiscal 2026 results, wherein both top and bottom lines surpassed the Zacks Consensus Estimate. The company delivered solid year-over-year
Do Options Traders Know Something About Tripadvisor Stock We Don't?
Investors in Tripadvisor, Inc. TRIP need to pay close attention to the stock based on moves in the options market lately. That is because the June 18, 2026 $5.00 Call had some of the highest implied
MAMA Stock: The One-Stop-Shop Deli Strategy Could Be a 2027 Theme
Mama’s Creations, Inc. MAMA is pushing beyond a single-brand identity and positioning itself as a broader refrigerated prepared-foods platform. The company is scaling distribution, widening its
Can MRK's New Drugs & Pipeline Aid Long-Term Growth Post Keytruda LOE?
Merck MRK has been betting on its newer products and a promising set of pipeline candidates to drive long-term growth as its blockbuster PD-1 inhibitor, Keytruda intravenous (IV), approaches patent
Ambarella's Q1 Earnings Meet Estimates, Revenues Rise on Auto Strength
Ambarella, Inc. AMBA delivered non-GAAP earnings of 11 cents per share in the first quarter of fiscal 2027, in line with the Zacks Consensus Estimate. Quarterly earnings jumped 57% year over year
CrowdStrike Set to Report Q1 Earnings: How to Play the Stock?
CrowdStrike Holdings CRWD is scheduled to report its first-quarter fiscal 2027 results on June 3, 2026.
CrowdStrike anticipates revenues between $1.36 billion and $1.364 billion for the first
MAMA Stock: Buy, Hold, or Watch? A Risk-Reward Checklist
Mama’s Creations, Inc. MAMA is scaling into a national, multi-brand deli-prepared foods platform with expanding distribution and supportive category trends. The push comes with trade-offs. The
Leveraged ETFs for Investors Seeking Bold Tactical Opportunities
Investors no longer appear to be as rattled by the Middle East conflict as they were during its initial stages. While uncertainty surrounding a potential peace deal between Washington and Tehran
Best Momentum Stock to Buy for May 29th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 29th:
Lifetime Brands LCUT: This company, which is a leading designer, marketer and
Is FGI's Brands, Products and Channels Strategy Starting to Pay Off?
FGI Industries Ltd.’s FGI first-quarter 2026 results suggest that its Brands, Products and Channels (“BPC”) strategy is beginning to generate encouraging signs, even as the broader housing and
Block's Cash App: Can Banking Engagement Keep Scaling?
Block’s XYZ banking engagement strategy is continuing to gain momentum as Cash App evolves from a peer-to-peer payments platform into a broader consumer financial ecosystem. The company’s core
FDA Grants Priority Review to SNY's Filing for Gaucher Disease Drug
Sanofi SNY announced that the FDA has accepted its new drug application (NDA) seeking approval for venglustat, an investigational oral glucosylceramide synthase inhibitor, for the treatment of
Bioventus (BVS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
The price trend for Bioventus (BVS) has been bearish lately and the stock has lost 6.6% over the past week. However, the formation of a hammer chart pattern in its last trading session indicates
Wall Street Analysts Predict a 37.26% Upside in LifeStance Health (LFST): Here's What You Should Know
Shares of LifeStance Health Group (LFST) have gained 3.2% over the past four weeks to close the last trading session at $7.81, but there could still be a solid upside left in the stock if short-term
After Golden Cross, AbCellera Biologics Inc. (ABCL)'s Technical Outlook is Bright
From a technical perspective, AbCellera Biologics Inc. (ABCL) is looking like an interesting pick, as it just reached a key level of support. ABCL's 50-day simple moving average crossed above its
AUTOTRADER GRP (ATDRY) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
The price trend for Auto Trader Group (ATDRY) has been bearish lately and the stock has lost 6.2% over the past week. However, the formation of a hammer chart pattern in its last trading session
Cadence Design Systems (CDNS)'s Technical Outlook is Bright After Key Golden Cross
Cadence Design Systems, Inc. (CDNS) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, CDNS's 50-day simple moving average broke out
Wall Street Analysts Predict a 30.97% Upside in TWFG, Inc. (TWFG): Here's What You Should Know
TWFG, Inc. (TWFG) closed the last trading session at $18.76, gaining 1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts Predict a 30.51% Upside in Transportadora De Gas Ord B (TGS): Here's What You Should Know
Shares of Transportadora De Gas Sa Ord B (TGS) have gained 0.9% over the past four weeks to close the last trading session at $30.78, but there could still be a solid upside left in the stock if




